CoChat

Novel patient-reported outcomes (PROs) used in a pilot and feasibility study of a Cognitive Behavioral Coping Skills (CBCS) group intervention for patients with chronic hepatitis C

Open access
Evon, Donna M., Golin, Carol E., Ruffin, Rachel, Ayres, Shauna, Fried, Michael W. · 2018 · Pilot and Feasibility Studies

The DOI matches its Crossref record; 49 of the 52 references it cites were found in a registry or an index; 14 of the 32 sources its claims cite were checked for support.

Abstract

Background: Patients with chronic hepatitis C virus (HCV) experience reduced quality of life, HCV-associated symptoms, comorbid conditions, and treatment side effects. The Cognitive Behavioral Coping Skills group intervention for HCV (CBCS-HCV) was developed using the Stage Model of Behavioral Therapies Research. Intervention development and initial feasibility testing in wave 1 participants were previously reported. The primary objective of this subsequent pilot with wave 2-3 participants was to investigate the effect sizes and clinical improvements in patient-reported outcomes (PROs) and trial and intervention feasibility. Methods: A pilot feasibility two-arm randomized controlled trial using block randomization to assign patients to CBCSHCV or standard of care was conducted. Participants attended nine group sessions: Four before HCV treatment and five during treatment. PRO data were collected at five time points: Before the CBCS intervention (T1), immediately before HCV treatment (T2), during HCV treatment (T3, T4), and 1 month post-intervention/post-HCV treatment (T5). PROs included quality of life, perceived stress, HCV symptoms, and medication adherence. Cohen's d was used to estimate within-group changes (WGCs) and between-group differences (BGDs), with d > 0.35 considered potentially clinically significant. Potential mechanisms of change were also evaluated. Results: Several WGCs and BGDs (ES > .35) suggest that the CBCS-HCV may promote improvements in PROs: Psychological stress, depression, anger, anxiety, sleep disturbance, and fatigue. The intervention did not appear to impact social functioning, pain, or medication adherence. Cognitive behavioral skills and group therapy dynamics, but not HCV treatment self-efficacy, may mediate improvements in PROs. Most aspects of the study trial, including intervention implementation, were feasible. Patient acceptance and retention were exceptional. The greatest feasibility challenge was due to patients needing to initiate treatment as soon as medications were obtained, but often before a full block could be created in wave 3. Challenges with PRO data collection were identified that will be resolved in future studies. Conclusions: The CBCS-HCV intervention warrants future investigation in an efficacy trial to evaluate improvements in selected PROs. The next step is to pilot test the CBCS-HCV delivered via telehealth to an expanded pool of patients to reduce patient barriers, hone technical logistics, and improve intervention reach and effectiveness. © The Author(s). 2018.

Overview

CoChat Summary

## TL;DR

This pilot two-arm randomized controlled trial tested a 9-session Cognitive Behavioral Coping Skills intervention for people with chronic hepatitis C against standard of care and found promising effect sizes for several patient-reported outcomes, especially stress and mental health symptoms. Feasibility was generally strong, with 20/22 randomized participants retained, 100% retention among those who started CBCS-HCV, and 89% overall PROM data completion.

## Key findings

  • The study screened 64 patients; 27 (42%) consented, 22 of those (81%) were randomized, and 20/22 (91%) were retained to the end of the study.
  • After four CBCS sessions (T1–T2), the intervention showed potentially clinically significant improvements (ES > .35) in overall HRQOL (.38), physical well-being (.44), perceived stress (.53), anger (.48), anxiety (.43), sleep disturbance (.51), pain intensity (.64), and pain interference (.37); between-group differences at T2 were also large for some outcomes, including physical well-being (.90) and stress (.90).
  • At 1 month post-intervention/post-treatment (T5), the CBCS group showed moderate improvements in depression (.55), anger (.46), anxiety (.55), fatigue (.52), sleep disturbance (.53), and sleep-related impairment (.48), but not in pain outcomes.
  • Medication adherence did not differ between groups: pill counts were 96% (84–100%) for CBCS and 98% (91–100%) for standard of care, self-reported adherence was 99.9% vs 99.6%, and 100% of patients in both groups had undetectable HCV RNA at 4 or 12 weeks post-treatment.

## Methods

  • Pilot feasibility two-arm randomized controlled trial with block randomization to CBCS-HCV (n = 12) or standard of care (n = 12), conducted across waves 2 and 3.
  • Participants attended nine 2-hour group sessions: four before HCV treatment and five during treatment; the sample consisted of patients prescribed 12-week HCV regimens, and patients co-infected with HIV or hepatitis B were included.
  • PROs were collected at five time points (T1–T5) and analyzed descriptively with Cohen’s d for within-group changes and between-group differences; no statistical significance tests were conducted because this was a pilot study.

## Limitations

  • The paper states that recruitment was difficult because patients needed to start HCV treatment quickly after obtaining medications, which sometimes prevented full block randomization.
  • The paper states that PRO data collection had challenges; overall completion was 89%, with lower completion at T2 (75%) and T5 (80%), partly because some standard-of-care participants lacked regular clinic visits or did not return mailed surveys.
  • Evident from the text: the study was small and exploratory (22 randomized; 20 retained), used effect sizes rather than hypothesis tests, and therefore cannot establish efficacy.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s40814-018-0285-5

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 PROMIS depression
Fig. 1 PROMIS depressionCC BY · PubMed Central
Fig. 2 PROMIS anger
Fig. 2 PROMIS angerCC BY · PubMed Central
Fig. 3 PROMIS anxiety
Fig. 3 PROMIS anxietyCC BY · PubMed Central
Fig. 4 PROMIS sleep disturbance
Fig. 4 PROMIS sleep disturbanceCC BY · PubMed Central
Fig. 5 PROMIS sleep-related impairment
Fig. 5 PROMIS sleep-related impairmentCC BY · PubMed Central
Fig. 6 PROMIS fatigue
Fig. 6 PROMIS fatigueCC BY · PubMed Central
Fig. 7 PROMIS pain intensity
Fig. 7 PROMIS pain intensityCC BY · PubMed Central
Fig. 8 PROMIS pain interference
Fig. 8 PROMIS pain interferenceCC BY · PubMed Central
Fig. 9 Study flowchart. Note: two participants withdrew after randomization and baseline due to transportation issues and delays in treatment. Period of time in which both the CBCS-HCV and SC groups received HCV treatment. Period of time in which only the CBCS-HCV received the CBCS intervention. Intervention group. Standard of care group. Measurement time points
Fig. 9 Study flowchart. Note: two participants withdrew after randomization and baseline due to transportation issues and delays in treatment. Period of time in which both the CBCS-HCV and SC groups received HCV treatment. Period of time in which only the CBCS-HCV received the CBCS intervention. Intervention group. Standard of care group. Measurement time pointsCC BY · PubMed Central

Verification

Claims the paper makes

12 Valid · 3 Not valid · 8 Not checked · 85 Own results and interpretations

41 more claims

Create a free account to see all 108 claims and to verify the 1 reference still open.

See all claims — free account
  • It may state two separate claims as one. 52
  • Probably not a substantial claim. 15

Create a free account to see these claims.

Citations

Cites

Show all 49 references

Research works printed but not linked: 1

  1. MacKenzie KL, Livesly WJ, editors. A developmental model for brief group therapy: advances in group therapy: integrating research and practice. New York: International Universities Press; 1983.

Cited by

See all 8

Metadata

Authors
Evon, D. M., Golin, C. E., Ruffin, R., Ayres, S., & Fried, M. W.
Affiliations
  • University of North Carolina at Chapel Hill (US)
  • Durham VA Medical Center (US)
Corresponding author
Evon, Donna M.
Venue
Pilot and Feasibility Studies
Published
2018-06-27
Volume
4
Issue
1
Pages
92-92
ISSN
2055-5784 (ISSN-L)
OpenAlex
W2806472463
Cited by
8
References
52
Citations by year
2025: 2 · 2022: 1 · 2021: 4 · 2018: 1
FWCI
0.78
Type
journal article
Language
en
Open access
Licence
Locations
  • Pilot and Feasibility Studies (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UNC Libraries
Funders
  • National Institute of Diabetes and Digestive and Kidney Diseases (K23DK089004-04, K24DK066144, DK034987)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (K24HD06920)
  • National Institute of Allergy and Infectious Diseases (P30AI450410)
Topics
  • Health Sciences › Medicine › Hepatology › Hepatitis C virus research
  • Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords
chronic hepatitis C, group intervention, patient-reported outcomes, quality of life, perceived stress, medication adherence, depression, anxiety, sleep disorders, fatigue, mechanisms of change, intervention feasibility, telemedicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Novel patient-reported outcomes (PROs) used in a pilot and feasibility study of a Cognitive Behavioral Coping Skills (CBCS) group intervention for patients with chronic hepatitis C. https://app.cochat.ai/papers/10.1186/s40814-018-0285-5
The paper
Evon, D. M., Golin, C. E., Ruffin, R., Ayres, S., & Fried, M. W. (2018). Novel patient-reported outcomes (PROs) used in a pilot and feasibility study of a Cognitive Behavioral Coping Skills (CBCS) group intervention for patients with chronic hepatitis C. Pilot and Feasibility Studies. https://doi.org/10.1186/s40814-018-0285-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.